5mg / Lyophilized *MUST BE RECONSTITUTED*
Introducing TB-500 Peptide – Also known as Thymosin Beta 4 or TB-4, this synthetic peptide mirrors the natural protein Thymosin beta 4, offering researchers a promising avenue for exploration. With properties akin to its natural counterpart, TB-500 may play a role in inducing angiogenesis, accelerating wound healing, and even influencing aspects like tumor cell metastasis and hair growth.
This 43 amino acid-containing peptide boasts high solubility in water and a lightweight structure. Abundant in wound fluid, particularly in the company of multiple blood platelets, TB-500 holds the potential for anti-inflammatory effects. It may not only support neurological healing but also contribute to the healing processes in critical areas such as the spinal cord, heart, and dermis.
In 1964, Dr. Goldstein and his professor Abraham White conducted research that mainly focused on the thymus gland and its functionality. They isolated the small proteins secreted by the thymus gland, located below the breast bone and above the heart and discovered Thymosin. During the course of the study, it was suggested by the research team that thymus gland functioning may impact immune deficiency and hormone release.(2)
In 1999, a research study was conducted on wounded rat test models, who were introduced to TB-500. Four days after the presentation, it was reported by the researchers that the TB-500 peptide rats exhibited an apparent 41% increase in re-epithelialization than control rats presented with saline. Seven days after the study, the TB-500 wounds were reported to be contracted by at least 11% more than the saline wounds. Upon analysis, it was concluded that TB500 may possibly induce angiogenesis and collagen deposition, increasing the wound healing rate.
Research studies were carried out on normal rats and mice, diabetic mice, aged mice, and steroid-influenced rats. All these animals were served full-thickness punch wounds, and introduced to the TB-500 peptide. It was reported that the TB-500 appeared to accelerate the wound-healing process in all test models, regardless of the stated pre-existing conditions. Furthermore, phase 2 clinical trials were conducted on test subjects with stasis and pressure ulcers. It was reported that TB-500 might accelerate the healing process by as much as one month.(6)
Pulmonary hypertension is considered by scientists to be a progressive cardio disease where the pulmonary arteries restrict the blood ejection by the right ventricle. This may result in increased pulmonary vascular resistance and pressure, potentially leading to ventricular failure of the heart. It was reported by reasearchers that TB-500 might be action specific on the Notch3-Col 3A-CTGF gene axis in MCT-influenced mice, which appeared to result in the case of the test study in decreasing the right ventricular hypertrophy by a significant amount.(7)
In 2003, studies were carried out on mice to examine the potential of TB-500 in hair growth. Under the influence of the TB-500 peptide, it was reported by the researchers that, via histological examination of the mouse skin cells, the peptide appeared to increase the number of hair shafts and hair follicles, thereby inducing hair growth. Upon real-time PCR and western blotting techniques, changes in the expression of m-RNA cells were observed between the TB500 and control mice. The m-RNA and protein levels were reported elevated in TB-500 mice, which might have significantly induced hair growth.(8)
At Gentera Med Peptides, pride in our craftsmanship is at the heart of everything we do. Our commitment to excellence and attention to detail ensure that every project we undertake meets the highest standards of quality and durability.
General Information: info@genteramed.com
Orders: gentera@peptide-fulfillment.com
Mon – Thurs / Excluding holidays
Orders placed and paid for after 12PM PST are shipped the following business day
550 Biltmore Way Suite 101,
Coral Gables, FL 33134
© 2024 Gentera Peptides, Inc. All Rights Reserved.
The statements made on this website have not been evaluated by the US Food and Drug Administration. The statements and the products of this company are not intended to diagnose, treat, cure, or prevent any disease.